A Phase 1 Open Label Study to Evaluate the Pharmacokinetics and Safety of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The study is being done to learn more about the safety of the combination of lumacaftor and ivacaftor and to learn about what happens when the Study Drugs are given to children with a certain type of cystic fibrosis.
Description
The study is being done to learn more about the safety of the combination of lumacaftor and ivacaftor and to learn about what happens when the Study Drugs are given to children with a certain type of cystic fibrosis.
Details
| Condition | Cystic Fibrosis |
|---|---|
| Age | 6years - 11years |
| Clinical Study Identifier | TX3470 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.